TGF-β and RAS jointly unmask primed enhancers to drive metastasis

Jun Ho Lee,Francisco J Sánchez-Rivera,Lan He,Harihar Basnet,Fei Xavier Chen,Elena Spina,Liangji Li,Carles Torner,Jason E Chan,Dig Vijay Kumar Yarlagadda,Jin Suk Park,Carleigh Sussman,Charles M Rudin,Scott W Lowe,Tuomas Tammela,Maria J Macias,Richard P Koche,Joan Massagué

DOI: https://doi.org/10.1016/j.cell.2024.08.014

IF: 64.5

2024-08-29

Cell

Abstract:Epithelial-to-mesenchymal transitions (EMTs) and extracellular matrix (ECM) remodeling are distinct yet important processes during carcinoma invasion and metastasis. Transforming growth factor β (TGF-β) and RAS, signaling through SMAD and RAS-responsive element-binding protein 1 (RREB1), jointly trigger expression of EMT and fibrogenic factors as two discrete arms of a common transcriptional response in carcinoma cells. Here, we demonstrate that both arms come together to form a program for lung adenocarcinoma metastasis and identify chromatin determinants tying the expression of the constituent genes to TGF-β and RAS inputs. RREB1 localizes to H4K16acK20ac marks in histone H2A.Z-loaded nucleosomes at enhancers in the fibrogenic genes interleukin-11 (IL11), platelet-derived growth factor-B (PDGFB), and hyaluronan synthase 2 (HAS2), as well as the EMT transcription factor SNAI1, priming these enhancers for activation by a SMAD4-INO80 nucleosome remodeling complex in response to TGF-β. These regulatory properties segregate the fibrogenic EMT program from RAS-independent TGF-β gene responses and illuminate the operation and vulnerabilities of a bifunctional program that promotes metastatic outgrowth.